MK-8591A clinical trials

Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)

This study is an ongoing look at a two-drug tablet called MK-8591A for people with HIV-1. It's for those already taking this medicine in previous studies to see how safe and effective it is over a longer time.